Cargando…
Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort
BACKGROUND: Given concerns over immune function, the decision whether to continue disease modifying therapy (DMT) in multiple sclerosis (MS) patients during the COVID-19 pandemic has been challenging, complicated by the risk of MS disease progression in the absence of treatment. METHODS: This retros...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B. V
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188116/ https://www.ncbi.nlm.nih.gov/pubmed/35724529 http://dx.doi.org/10.1016/j.msard.2022.103964 |